Cancer Research  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 50, 4272-4276, July 15, 1990]
© 1990 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Perry, R. R.
Right arrow Articles by Pass, H. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Perry, R. R.
Right arrow Articles by Pass, H. I.

Sensitivity of Different Human Lung Cancer Histologies to Photodynamic Therapy

Roger R. Perry, Wilbert Matthews, James B. Mitchell, Angelo Russo, Steven Evans and Harvey I. Pass1

Thoracic Oncology Section, Surgery Branch [R. R. P., W. M., S. E., H. I. P.], and the Radiation Oncology Branch [J. B. M., A. R.], National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892

The relative sensitivities of different cancer histologies in a single site to photodynamic therapy (PDT) are unknown and methods to predict PDT sensitivity have not been described. The in vitro response to PDT of six established human lung cancer cell lines and one normal lung fibroblast cell line was studied using the clonogenic assay. Dose-response curves were determined for cells incubated in 25 µg/ml of Photofrin II for 2 h, followed by exposure to 630-nm light to total energies of 0-3150 J/m2. None of the cell lines were sensitive to sensitizer alone or light alone. Differences in inherent PDT sensitivities as evaluated by survival curve parameters n, Do, and light dose to yield 1% survival were observed among the cell lines. No clear correlation was found when inherent PDT sensitivity was compared with sensitizer uptake; however, a general association was noted between PDT sensitivity and the plating efficiency of the cell line. These data illustrate that differences in inherent PDT exist for in vitro systems. Such differences may explain some of the failures seen in clinical PDT.

1 To whom requests for reprints should be addressed, at Head, Thoracic Oncology Section, Surgery Branch, National Cancer Institute, NIH, Building 10, Room 2B07, Bethesda, MD 20892.

Received 6/20/89. Revised 2/19/90.


This article has been cited by other articles:


Home page
ChestHome page
D. I. Fielding, G. A. Buonaccorsi, A. J. MacRobert, A. M. Hanby, M. R. Hetzel, and S. G. Bown
Fine-Needle Interstitial Photodynamic Therapy of the Lung Parenchyma: Photosensitizer Distribution and Morphologic Effects of Treatment
Chest, February 1, 1999; 115(2): 502 - 510.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1990 by the American Association for Cancer Research.